Waddell & Associates’s Chemed CHE Stock Holding History

Waddell & Associates’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$539K	Buy	1,158 +561	+94%	+$236K	0.03%	259
2026 Q1	$226K	Buy	+597	New	+$256K	0.01%	397

Other funds holding CHE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Waddell & Associates's CHE Position: Q2 2026 in Review

Waddell & Associates increased its Chemed (CHE) stake by 94% in Q2 2026, buying an estimated $236K and bringing the position to 1,158 shares worth $539K. The position accounts for 0.03% of the portfolio, ranked #259.

Waddell & Associates first reported a position in CHE in Q1 2026 and has held it in 2 quarters since. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

Waddell & Associates held 1,158 shares of Chemed worth $539K as of Q2 2026.
Waddell & Associates bought 561 Chemed shares in Q2 2026, an estimated $236K.
Chemed made up 0.03% of Waddell & Associates's portfolio in Q2 2026, its #259 holding.
Waddell & Associates first reported a position in Chemed in Q1 2026 and has held it in 2 quarters since.
532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Waddell & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.